Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Institut du Cancer de Montpellier - Val d'Aurelle
M.D. Anderson Cancer Center
University of Alabama at Birmingham
Seagen Inc.
City of Hope Medical Center
Washington University School of Medicine
Sensei Biotherapeutics, Inc.
Jonsson Comprehensive Cancer Center
University of Alabama at Birmingham
Revolution Medicines, Inc.
Elevation Oncology
UNC Lineberger Comprehensive Cancer Center
Cedars-Sinai Medical Center
Universitair Ziekenhuis Brussel
M.D. Anderson Cancer Center
Genmab
Kineta Inc.
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Main Line Health
Albert Einstein College of Medicine
Instituto do Cancer do Estado de São Paulo
Instituto do Cancer do Estado de São Paulo
Bay Area Gynecology Oncology
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
Duke University
Ohio State University Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
ImmunoFrontier, Inc.
St. Luke's-Roosevelt Hospital Center
University of Copenhagen
New Mexico Cancer Research Alliance
Astellas Pharma Inc